AXIS-2: G-CSF Fails to Improve Recovery After StrokeAXIS-2: G-CSF Fails to Improve Recovery After Stroke
AX200, a novel neuroprotectant, was no better than placebo in improving functional outcomes in phase 2 testing. Medscape Medical News (Source: Medscape Today Headlines)
New Alzheimer’s Guidelines May Confuse Diagnosis
Under recently revised criteria, nearly all people currently diagnosed with very mild or mild Alzheimer’s disease dementia would be classified instead as having mild cognitive impairment, akin to slight memory loss, which could mislead patients and their families, according to a leading Alzheimer’s researcher. (Source: WebMD Health)